865663-86-1 Usage
General Description
5-Fluoro-thiazolo[5,4-b]pyridin-2-ylaMine is a chemical compound with potential pharmacological and medicinal applications. It is a thiazole-based chemical with a fluorine atom and a pyridine ring, making it a heterocyclic compound. This chemical compound has potential applications in drug development and medicinal chemistry due to its structural features and potential interactions with biological systems. Its unique structure and properties make it a promising candidate for the development of new pharmaceuticals and biologically active compounds. Additionally, its potential medicinal applications make it an important compound for further research and development in the field of pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 865663-86-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,5,6,6 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 865663-86:
(8*8)+(7*6)+(6*5)+(5*6)+(4*6)+(3*3)+(2*8)+(1*6)=221
221 % 10 = 1
So 865663-86-1 is a valid CAS Registry Number.
865663-86-1Relevant articles and documents
Α 7 as intranuclear hydroxynicotinic acetylcholine receptor quinuclidines compd.
-
Paragraph 0683; 0684, (2018/10/03)
PROBLEM TO BE SOLVED: To provide ligands for the nicotinic α-7 receptor used for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.SOLUTION: The disclosure provides compounds of the specified formula I, including their salts, and compositions and methods using the compounds.
QUINUCLIDINE, 1-AZABICYCLO[2.2.1]HEPTANE, 1-AZABICYCLO [3.2.1]OCTANE, and 1-AZABICYCLO[3.2.2]NONANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
-
Page/Page column 90; 91, (2014/01/07)
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
